Matt Downing Takes the Reins as HNF’s New Board Chairman 

by | Sep 3, 2020 | 0 comments

The Hereditary Neuropathy Foundation (HNF) is happy to announce on July 1, 2020, that Matt Downing has been selected as Chairman of the HNF Board of Directors. Matt, a CMT patient and a father of three children with CMT, has been serving as an HNF board member for over 10 years and most recently held the role of Board Secretary. We are thrilled to have Matt take this leadership role and excited to see what the future holds for HNF!

Matt is currently the Chief Marketing and Innovations Officer at MedPower, a cloud-based online learning company focused on serving the healthcare industry. In his role as CMO, Matt leads MedPower’s global marketing and product teams, guiding the company’s marketing strategy, product development, communications, branding and analytics.

Prior to MedPower, Matt served as Chief Marketing Officer at TriPlay, a personal cloud services and audio entertainment start-up in New York City. Prior to TriPlay, Matt ran sales and marketing for SiriusXM’s Streaming Services and Direct to Consumer divisions. During his tenure, Matt helped SiriusXM grow from a small satellite radio start-up to the world’s largest radio broadcaster with over 27 million subscribers. Prior to SiriusXM, Matt served as VP, Marketing at DIRECTV and ran a variety of national accounts for both Grey Advertising and Young & Rubicam. Matt is a graduate of the University of Michigan, where he studied marketing and business management. 

Special thanks to Joy Kaye for her years of service to HNF. We are happy to report that Joy will continue to participate as an HNF board member.

Learn more on this topic

Related Blog Posts

Dr. Sean Ekins named C.S.O. of HNF

We are delighted to announce that after volunteering for HNF for the past year Dr. Sean Ekins, Ph.D, D.Sc. will officially become our CSO responsible for overseeing the TRIAD program, directing our scientific advisory board, and communicating our research initiatives to the scientific community. In addition he serves as the Principal Investigator of the clinical Global Registry for Inherited Neuropathy (GRIN).

Join the conversation

Leave a Comment


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news